SG/CALL/ABBOTT LABORATORIES/150/0.1/20.06.25 Stock

Warrant

DE000SW7ME12

Real-time Boerse Frankfurt Warrants 12:28:56 2024-05-15 EDT
0.07 EUR +7.69% Intraday chart for SG/CALL/ABBOTT LABORATORIES/150/0.1/20.06.25
Current month-40.91%
1 month-65.79%
Date Price Change
24-05-15 0.07 +7.69%
24-05-14 0.065 -14.47%
24-05-13 0.076 -11.63%
24-05-10 0.086 +14.67%
24-05-09 0.075 -14.77%

Real-time Boerse Frankfurt Warrants

Last update May 15, 2024 at 12:28 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW7ME1
ISINDE000SW7ME12
Date issued 2024-03-12
Strike 150 $
Maturity 2025-06-20 (401 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.43
Lowest since issue 0.059
Spread 0.01
Spread %12.66%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104 USD
Average target price
126.1 USD
Spread / Average Target
+21.28%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW